Healthcare AI investors writing $25M+ checks

Investors whose typical check size falls in the $25M+ range for healthcare AI deals. Useful for sizing your round and identifying the right tier of partners.

Checks exceeding $25 million characterize extreme late-stage mega-rounds (Series C, D, and beyond) or massive private equity buyouts. In the AI and MedTech sectors, this capital supports profound infrastructural development, global scaling, and massive clinical deployments.
145 investors match

Within $25M+: top investment stages

Growth (140) Series C (55) Series B (44) Series A (28) Series D+ (22) Seed (14) Pre-Seed (4) Post-IPO (2)
5AM Ventures
VC T1
Menlo Park, United States
$25M+
5AM Ventures is a pure-play life sciences firm that has been quietly defining the early-stage biotech category from Menlo Park since 2002.…
Biotech Life Sciences Tools
8VC
VC AI T1
Austin, United States
$25M+
8VC is the kind of firm that requires founders to read past the marketing copy. Joe Lonsdale’s Austin-based partnership, with over $6B…
AI/ML in Healthcare Biotech
Abry Partners
PE T3
Boston, United States
$25M+
Abry Partners is a Boston-based private equity firm that executes large-scale buyouts and growth equity investments, with a particular concentration in healthcare…
Health IT / Healthcare Software
Accelmed
PE T1
Miami, United States
$25M+
Accelmed sits in a corner of healthcare investing that most venture firms quietly avoid: commercial-stage HealthTech that is too capital-intensive for traditional…
Care Delivery / Tech-Enabled Services Diagnostics
Advent International
PE T3
Boston, United States
$25M+
Advent International is one of the larger global private equity firms, headquartered in Boston with offices across multiple continents. Within healthcare, the…
Diagnostics Pharma / Therapeutics
Ahmed Al-Mukhalalati
PE T3
Abu Dhabi, United Arab Emirates
$100k-$250k
Ahmed Al-Mukhalalati is an Abu Dhabi-based solo angel investor and capital manager whose principal role is Founder of Olive Rock Partners. His…
Care Delivery / Tech-Enabled Services Health IT / Healthcare Software
Aisling Capital
VC T1
New York, United States
$25M+
Aisling Capital is the New York-based life sciences specialist whose name is most often associated with the Loxo Oncology deal, the targeted…
Biotech Diagnostics
Alibaba Health Information Technology
Corporate VC AI T3
Beijing, China
$25M+
Alibaba Health Information Technology is the digital health operating arm and strategic investment vehicle of Alibaba, headquartered in Beijing with operational responsibility…
Care Delivery / Tech-Enabled Services Digital Health
ARCH Venture Partners
VC AI T1
Chicago, United States
$25M+
ARCH does not chase deal flow. It manufactures it. Since 1986 the Chicago firm has built a reputation for co-founding companies with…
AI/ML in Healthcare Biotech
Ares Management LLC
PE T3
Los Angeles, United States
$25M+
Ares Management is a global alternative investment manager headquartered in Los Angeles, with strategies spanning credit, private equity, real estate, and infrastructure.…
Care Delivery / Tech-Enabled Services
Arsenal Capital Partners
PE T3
New York, United States
$25M+
Arsenal Capital Partners is a New York-based private equity firm that builds platforms in two industries: healthcare and specialty industrials. On the…
Life Sciences Tools Pharma / Therapeutics
Ascend Partners
PE T3
New York, United States
$25M+
Ascend Partners is a New York-based private equity firm focused exclusively on healthcare, with a particular emphasis on partnering with physician practices…
Care Delivery / Tech-Enabled Services
Asia Partners
PE T2
Singapore, Singapore
$25M+
Asia Partners is a Singapore-based growth equity firm deploying $25M+ cheques at Series B, Series C, and growth into mid-market technology platforms…
Digital Health
AstraZeneca Strategic Partnering
Corporate VC AI T3
Cambridge, United Kingdom
$25M+
AstraZeneca Strategic Partnering is the corporate venture and partnering arm of one of the world’s largest pharmaceutical companies, operating from AstraZeneca’s Cambridge…
AI/ML in Healthcare Biotech
Audax Private Equity
PE T3
Boston, United States
$25M+
Audax Private Equity is a Boston-based middle-market firm best known for its buy-and-build strategy, which involves acquiring a platform company and aggressively…
Care Delivery / Tech-Enabled Services
AI Tool Finder
AI-powered search. Results may not be comprehensive.